Literature DB >> 15277351

Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.

Sofie Joossens1, Marco Daperno, Zakera Shums, Kristel Van Steen, James A Goeken, Claudio Trapani, Gary L Norman, Godelieve Godefridis, Greet Claessens, Angelo Pera, Marie Pierik, Severine Vermeire, Paul Rutgeerts, Xavier Bossuyt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15277351     DOI： 10.1373/clinchem.2004.032318

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

Review 1.  Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

Authors:  Epameinondas V Tsianos; Konstantinos Katsanos
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

2.  Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.

Authors:  Maria Teresa Arias-Loste; Geovana Bonilla; Irene Moraleja; Michael Mahler; Miguel Angel Mieses; Beatriz Castro; Montserrat Rivero; Javier Crespo; Marcos López-Hoyos
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 3.  Utility of serological markers in inflammatory bowel diseases: gadget or magic?

Authors:  Maria Papp; Gary L Norman; Istvan Altorjay; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

4.  Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Authors:  Maria Papp; Istvan Altorjay; Gabriella Lakos; Judit Tumpek; Sandor Sipka; Tamas Dinya; Karoly Palatka; Gabor Veres; Miklos Udvardy; Peter Laszlo Lakatos
Journal:  Clin Vaccine Immunol       Date:  2009-02-04

5.  PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).

Authors:  Laura M Stinton; Chelsea Bentow; Michael Mahler; Gary L Norman; Bertus Eksteen; Andrew L Mason; Gilaad G Kaplan; Bjorn Lindkvist; Gideon M Hirschfield; Piotr Milkiewicz; Angela Cheung; Harry L A Janssen; Marvin J Fritzler
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

6.  A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China.

Authors:  Su'e Shao; Meifang Huang; Heng Zhang; Gangqiang Peng; Min Song; Jing Liu; Dan Xu
Journal:  J Inflamm Res       Date:  2022-06-20

7.  Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis.

Authors:  Ilka Knütter; Rico Hiemann; Therese Brumma; Thomas Büttner; Kai Großmann; Marco Cusini; Francesca Pregnolato; Maria Orietta Borghi; Ursula Anderer; Karsten Conrad; Dirk Reinhold; Dirk Roggenbuck; Elena Csernok
Journal:  Arthritis Res Ther       Date:  2012-12-14       Impact factor: 5.156

Review 8.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.